Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.52 AUD | -0.66% | -0.44% | -6.22% |
30/04 | ImpediMed's Qaurterly Revenue Rises in Fiscal Q3; Shares Fall 8% | MT |
17/04 | Impedimed Implements Organizational Changes; Makes Strategy Chief, COO Redundant | MT |
Sales 2024 * | 297M 194M 16.19B | Sales 2025 * | 398M 261M 21.75B | Capitalization | 467M 306M 25.51B |
---|---|---|---|---|---|
Net income 2024 * | 21M 13.75M 1.15B | Net income 2025 * | 30M 19.64M 1.64B | EV / Sales 2024 * | 1.63 x |
Net Debt 2024 * | 17.01M 11.13M 928M | Net Debt 2025 * | 22.65M 14.83M 1.24B | EV / Sales 2025 * | 1.23 x |
P/E ratio 2024 * |
24.6
x | P/E ratio 2025 * |
15.3
x | Employees | - |
Yield 2024 * |
2.27% | Yield 2025 * |
3.04% | Free-Float | 69.3% |
Latest transcript on IPD Group Limited
1 day | -0.66% | ||
1 week | -0.44% | ||
Current month | -6.03% | ||
1 month | -4.24% | ||
3 months | -6.61% | ||
6 months | +17.71% | ||
Current year | -6.22% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 01/15/01 | |
Jason Boschetti
DFI | Director of Finance/CFO | - | 28/22/28 |
Mohamed Yoosuff
PRN | Corporate Officer/Principal | - | 01/05/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Moffat
BRD | Director/Board Member | 62 | 24/20/24 |
David Rafter
CHM | Chairman | - | 14/19/14 |
Chief Executive Officer | - | 01/15/01 |
Date | Price | Change | Volume |
---|---|---|---|
02/24/02 | 4.52 | -0.66% | 52 432 |
01/24/01 | 4.55 | -0.66% | 71,062 |
30/24/30 | 4.58 | -1.29% | 108,819 |
29/24/29 | 4.64 | +0.65% | 97,875 |
26/24/26 | 4.61 | -0.43% | 86,941 |
Delayed Quote Australian S.E., May 02, 2024 at 11:40 am IST
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.22% | 306M | |
-6.73% | 7.85B | |
+2.14% | 7.76B | |
+12.94% | 7.32B | |
+6.03% | 1.29B | |
+88.18% | 786M | |
-10.45% | 638M | |
-1.69% | 606M | |
+65.43% | 602M | |
+160.87% | 537M |
- Stock Market
- Equities
- IPG Stock